Actively Recruiting
Ultra-Low Contrast Angiography in AKI
Led by Tulane University · Updated on 2025-09-23
32
Participants Needed
2
Research Sites
64 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.
CONDITIONS
Official Title
Ultra-Low Contrast Angiography in AKI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitalized patients with acute kidney injury at admission or who develop acute kidney injury during admission and require invasive coronary angiography
You will not qualify if you...
- Stabilized kidney function with unchanged or improving serum creatinine during the 24 hours before enrollment
- Contraindications to invasive coronary angiography other than acute kidney injury
- Need for percutaneous coronary intervention that cannot be delayed by 7 days
- Requirement for renal replacement therapy before or planned after coronary angiography
- Use of intravascular contrast media within 7 days before or 6 days after coronary angiography
- Pregnancy, prisoner status, cognitive impairment, age under 18 years
- Unable or unwilling to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Tulane University Medical Center
New Orleans, Louisiana, United States, 70112
Actively Recruiting
2
University Medical Center
New Orleans, Louisiana, United States, 70112
Actively Recruiting
Research Team
Z
Zach Rozenbaum, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here